Latest Regulatory Approval News

Catalyst Metals has received regulatory approval to build an exploration tunnel at its Four Eagles gold project in Victoria, marking a pivotal step toward underground access and resource expansion. The company is advancing its high-grade gold resource with a secured processing facility and plans for further drilling in FY26.

Paladin Energy reports a record uranium production quarter at its Langer Heinrich Mine alongside a robust engineering review of its Patterson Lake South Project, supported by a successful A$300 million equity raise.

Forrestania Resources has initiated a scrip-based takeover offer for Kula Gold, valuing the company at nearly $59 million and promising regional consolidation in Western Australia's gold belt. The Kula board unanimously supports the deal, pending shareholder approval and regulatory conditions.

Forrestania Resources has launched a conditional script takeover bid for Kula Gold, offering a 41% premium and securing unanimous board support. The deal aims to accelerate value realisation from Kula’s Mt Palmer Gold Project.

Rio Tinto reported robust third quarter 2025 production results, highlighted by record outputs in bauxite and copper, and an upgraded bauxite production forecast. Key projects like Simandou and Oyu Tolgoi continue to progress on schedule, underpinning the company’s growth trajectory.

Tungsten Mining NL is moving to list on the U.S. OTCQB Market, aiming to tap into strong North American investor interest as tungsten prices climb and critical mineral security becomes a priority.

Latrobe Magnesium Limited (ASX – LMG) has launched an $8 million equity raising to fund the ramp-up of its magnesium metal production and advance feasibility studies for a larger commercial plant. The company’s patented hydromet process converts brown coal ash into sustainable magnesium with significantly lower emissions than global peers.

Australian Mines Limited has secured key approvals to begin a ~1,000m drilling program at its high-grade Flemington scandium project, positioning itself strategically amid tightening Chinese rare earth export controls.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.

PYC Therapeutics has reported encouraging pre-clinical results for its RNA therapy candidate PYC-002 targeting Phelan-McDermid Syndrome, supporting plans to enter human trials in 2026. The data demonstrate safety, brain distribution, and gene expression restoration in key disease regions.

Immuron Limited reports a robust 34% year-on-year sales increase for Q1 FY26, driven by strong growth in Australia and the USA, while Canadian sales dip seasonally. The company’s marketing efforts and expanding retail presence underpin this momentum.

Elementos Limited has executed a binding option agreement to acquire half of Iberian Smelting SL, owner of the Robledollano Tin Smelter in Spain, setting the stage for the EU's first vertically integrated primary tin supply chain.